Rapid diagnostic tests that read the immune system
#5 of 112 undisclosed-stage biotech startups
▲ 1 since the last ranking
Ranked 6:02 AM PT · Thu, Nov 19
Established
Inflammatix is developing rapid point-of-care diagnostic tests by reading the immune response aimed to help physicians better diagnose acute infections and sepsis.
If a fact is wrong, or you want the profile removed, tell us: we act on every request within 2 business days.